13 January 2014 - PHARMAC is pleased to announce the approval of proposals to amend access to sugammadex and atomoxetine and to fund baclofen injection in the community. These proposals were the subject of a consultation letter dated 29 November 2013 which can be found on PHARMAC’s website at http://www.pharmac.health.nz/news#consultation.

For more details, go to: http://www.pharmac.health.nz/news/item/atomoxetine-sugammadex-and-baclofen-injection